381
Participants
Start Date
April 30, 1998
Primary Completion Date
October 31, 1998
Meloxicam 7.5 mg
Meloxicam 3.75 mg
Meloxicam 1.875 mg
Ibuprofen 200 mg
Placebo
Meloxicam 15 mg
Ibuprofen 400 mg
Lead Sponsor
Boehringer Ingelheim
INDUSTRY